SCYNEXIS, Inc.
SCYXNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $46.23M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.57$9.12
- Volume (live)
- -
- Avg. volume (3M)
- 393.34K
SCYNEXIS (SCYX) Stock Price & Financial Analysis
SCYNEXIS Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.54 - $3.88 |
|---|---|
| 52-Week High | $9.12 |
| 52-Week Low | $0.57 |
| Open | $3.87 |
| Volume (last close) | 188.85K |
| Average Volume (3M) | 393.34K |
| Revenue (TTM) | 19.21M |
|---|---|
| Net Income (TTM) | -10.23M |
| Free Cash Flow (TTM) | -13.31M |
| EPS (TTM) | −$1.37 |
| Profit Margin | -53.27% |
| Operating Margin | -117.61% |
| Return on Equity (ROE) | -15.29% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 46.23M |
|---|---|
| Shares Outstanding | 11.82M |
| Price to Sales (P/S) | 2.41 |
| Price to Book (P/B) | 0.69 |
| EV/EBITDA | -3.68 |
| 50-Day MA | $4.87 |
|---|---|
| 200-Day MA | $4.54 |
| 1-Year Change | +418.16% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
SCYNEXIS at a Glance
As of the Oct 16, 2026 close, SCYNEXIS (SCYX) has a market capitalization of $46.23M. The stock trades at 2.4× sales. Over the trailing twelve months it lost $10.23M on revenue of $19.21M and burned $13.31M of free cash flow. Revenue grew 489.8% year over year.
As of its latest reported balance sheet, it holds $10.49M in cash and securities against $1.95M of debt, a net cash position of $8.54M.
SCYNEXIS does not currently pay a dividend.
The share price is up 418.2% over the past year. At $3.67 (the Oct 16, 2026 close) it sits within its 52-week range of $0.56 to $9.12, below its 200-day moving average of $4.54.
Frequently Asked Questions About SCYNEXIS
What is the current stock price for SCYX?
As of the Oct 16, 2026 close, SCYX stock trades at $3.67. The 52-week range is $0.57–$9.12, with a day range of $3.54–$3.88.
What is the P/E ratio for SCYX?
The P/E ratio (Price-to-Earnings) for SCYX is shown in the Key Statistics section. This valuation metric helps compare SCYNEXIS, Inc. to industry peers.
Does SCYX pay dividends?
SCYNEXIS does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SCYX?
Analyst ratings and recommendations for SCYX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SCYX?
As of the Oct 16, 2026 close, SCYNEXIS's market capitalization is $43.4M, classifying it as a micro-cap company. SCYNEXIS operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.